- €508.18m
- €911.66m
- €173.09m
- 53
- 68
- 48
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 125 | 164 | 135 | 164 | 173 |
Cost of Revenue | |||||
Gross Profit | 124 | 162 | 133 | 171 | 181 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 103 | 135 | 101 | 125 | 127 |
Operating Profit | 21.6 | 29.2 | 33.8 | 38.5 | 46 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21.1 | 49.3 | 55.3 | 44.5 | 41.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.5 | 58.7 | 45.3 | 37.5 | 36.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 493 | 58.7 | 45.3 | 39.2 | 36.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 493 | 58.7 | 45.3 | 39.2 | 36.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.067 | 0.275 | 0.214 | 0.117 | 0.157 |
Dividends per Share |